Functional Outcomes and Quality of Life in Patients with Extremity Soft Tissue Sarcoma: A Longitudinal Analysis at a Tertiary Care Teaching Hospital
Authors: Roy AK, Bang B*, Khan F
Journal: International Journal of Surgery & Surgical Techniques. Article type: Research Article. Published: 2026-10-19. DOI: https://doi.org/10.23880/ijsst-16000237
Abstract
Background: Soft tissue sarcomas (STS) of the extremities are rare malignancies whose treatment prioritizes both oncologic control, preservation of limb function and quality of life (QoL). Conventional survival metrics inadequately capture the functional and psychosocial impact of limb-salvage surgery and adjuvant therapies. Objective: To evaluate postoperative functional outcomes and QoL in patients with extremity STS treated by limb-salvage surgery at a tertiary care centre, and to identify associated clinical factors. Methods: This cross-sectional observational study enrolled 46 consecutive patients with extremity STS who underwent surgical management at Maharaja Yashwantrao Hospital (MY Hospital), Indore, between 2023 and 2024. Functional outcome was assessed with the Toronto Extremity Salvage Score (TESS) and QoL with the EORTC QLQ-C30 questionnaire at 1 week, 2 weeks, 4 weeks and 3 months postoperatively. Patient demographics, tumour factors, treatment methods and complication data were recorded. Statistical analysis used descriptive statistics, correlation coefficients, multivariate linear regression and ANOVA (SPSS; significance p < 0.05). Results: Mean age was 43.3 ± 16.9 years; 54 % were male. Upper-limb tumours predominated (57 %). Surgery alone was performed in 83 % of cases; flap reconstruction was required in 65 %. Mean TESS scores remained high and stable (80.4 at 1 week to 80.6 at 3 months). Mean QLQ-C30 scores showed an initial decline followed by stabilisation (82.1 at 1 week to 77.0 at 3 months). Multivariate regression demonstrated significant negative associations of age (β = −0.21, p = 0.03) and BMI (β = −0.34, p = 0.02) with TESS, and of age and BMI with QoL scores at 3 months. Postoperative complication rate was low (16 %). Local recurrence and distant metastasis rates were not the primary focus of the reported analyses. Conclusion: Limb-salvage surgery for extremity STS yields high and relatively stable functional scores and acceptable QoL in the early postoperative period. Older age and higher BMI independently predict poorer functional and QoL outcomes, underscoring the need for individualised rehabilitation and weight-management strategies. Larger prospective multicentre studies with longer follow-up are warranted.
Keywords: Soft Tissue Sarcoma, Extremity, Limb Salvage, Toronto Extremity Salvage Score, Quality of Life, TESS, QLQ-C30
Introduction
Soft tissue sarcomas (STS) of the extremities are a heterogeneous group of rare malignancies arising from mesenchymal tissues. The primary goal of treatment is local tumor control while preserving a functional limb [1,2]. Historically, radical amputation was the standard; however, advancements in surgical techniques and adjuvant therapies have shifted the paradigm toward limb-salvage surgery [3,4]. Despite the surgical success of limb preservation, the impact of these interventions on a patient’s functional capacity and health-related quality of life (HRQoL) remains a critical area of concern for clinicians and survivors alike [5,6]. Functional outcomes are increasingly measured using patient-reported outcome measures (PROMs) such as the Toronto Extremity Salvage Score (TESS), which focuses on physical tasks and emotional acceptance [7,8]. Simultaneously, HRQoL instruments like the EORTC QLQ-C30 provide insight into the broader impact of the disease and its treatment on a patient’s social, emotional, and physical well-being [6,9]. Understanding the relationship between these two metrics is essential for developing comprehensive rehabilitation strategies that address the multifaceted needs of sarcoma patients.
Methods
Study Design and Setting
This research was conducted as an observational cross- sectional and longitudinal analytical study at the Department of General Surgery, MY Hospital, M.G.M. Medical College in Indore, India. The study period spanned 12 months following ethical approval.
Participant Selection
A total of 46 patients diagnosed with extremity STS were enrolled using sequential sampling. Inclusion criteria encompassed patients of all ages and genders with localized disease undergoing surgical management who provided informed consent. Exclusion criteria included incomplete surgeries, pre-existing joint deformities, inoperable cases, and significant systemic comorbidities such as coronary heart disease or stroke.
Data Collection and Instruments
Patients underwent baseline demographic and clinical evaluation (age, BMI, tumor characteristics). Post-operative assessments were conducted at four specific intervals: 1 week, 2 weeks, 4 weeks, and 3 months. Functional outcomes were measured using the TESS, which evaluates pain, function, and emotional acceptance across 29–30 items, where higher scores indicate better function [8,10]. HRQoL was assessed using the EORTC QLQ-C30 questionnaire. Statistical analysis was performed using SPSS, with p < 0.05 considered significant.
Results
Forty-six patients fulfilled inclusion criteria. Mean age was 43.26 ± 16.93 years (range 19–70). Males comprised 54.3 % (n = 25). Age distribution was relatively even across decades 18–69 years. Mean BMI was 28.15 ± 4.74 kg/m²; 39% were overweight and 39% obese. Upper-extremity tumours accounted for 56.5% of cases, lower extremity for 43.5% cases. Primary surgery was performed in 82.6% of patients; flap reconstruction, either for skin or soft tissue defects, was required in 65.2 % cases. Adjuvant radiotherapy was needed in 8 (17.3%) cases. Postoperative complications occurred in 15.2 % of operated patients (wound infection 10.8 %, wound dehiscence 4.3 %). Mean TESS scores remained high and essentially stable: • 1 week: 80.35 ± 11.32 • 2 weeks: 79.76 ± 9.99 • 4 weeks: 79.83 ± 10.81 • 3 months: 80.57 ± 11.70 Mean QLQ-C30 scores showed a modest early decline followed by stabilisation: • 1 week: 82.09 ± 11.83 • 2 weeks: 79.24 ± 12.40 • 4 weeks: 78.13 ± 12.28 • 3 months: 77.04 ± 11.11 ANOVA confirmed significant change in QLQ-C30 scores over time (F = 23.45, p = 0.0001). Pairwise comparisons indicated a statistically significant difference between the 1-week and 3-month QLQ-C30 scores (p = 0.039); TESS scores did not differ significantly across time points.
Age and BMI exhibited weak-to-moderate negative correlations with both TESS and QLQ-C30 at all time points; none reached statistical significance on univariate testing. Multivariate regression at the 3-month assessment, however, identified age (TESS β = −0.21, p = 0.03; QoL β = −0.18, p = 0.04) and BMI (TESS β = −0.34, p = 0.02; QoL β = −0.28, p = 0.03) as independent negative predictors. Comorbidities showed a borderline association with TESS (p = 0.05). Gender and treatment modality were not significant.
Discussion
Functional Outcome Trends (TESS)
In the Indore cohort, the mean TESS scores remained relatively stable over the three-month follow-up period, starting at 80.35 ± 11.32 at one week and reaching 80.57 ± 11.70 at three months. This suggests that patients who underwent limb-sparing procedures maintained high levels of baseline functionality during the early post-operative phase.
Comparatively, Gazendam, et al. reported lower mean TESS scores in patients undergoing endoprosthetic reconstruction: 63.5 preoperatively, 67.9 at 3 months, and improving to 81.1 at 12 months [7]. Green, et al. similarly observed TESS scores improving from 80.9 at 16.7 months to 89.1 at 26.7 months [1]. Systematic reviews indicate that functional outcomes often decline initially up to 6 months postoperatively before plateauing and returning to baseline after one year [4,11]. The high initial scores in our study may reflect a cohort with less radical resections or a higher proportion of early-stage disease.
Quality of Life Trends (QLQ-C30)
Our study reported mean QLQ-C30 scores of 82.09 at one week, which slightly declined to 77.04 at three months. This downward trend in HRQoL despite stable physical function highlights a potential psychological or social adjustment phase following surgery. Kask et al. reported a similar mean QLQ-C30 score of 73 at a median follow-up of 62 months [6].
Correlation Between Function and HRQoL
The correlation analysis in the local study revealed a weak, non-significant negative relationship between TESS and QLQ-C30 scores (r ranging from -0.119 to -0.234; p=0.117 to 0.422). This implies that a patient’s perceived physical function does not directly dictate their overall quality of life during the early recovery period. In contrast, other studies have found that lower functional outcomes are significantly associated with poorer HRQoL in the long term [6,12].
Impact of Age and BMI
Advanced age was identified as a significant predictor of poorer functional outcomes in both the local Indore cohort and global literature. Gazendam et al. found that older age (per 10-year increase) was associated with worse TESS scores [7], and Oh, et al. noted that patients older than 47 years had significantly poorer functional recovery [11]. Similarly, higher BMI was strongly associated with lower TESS and QLQ-30 scores in our study, a finding corroborated by Kask, et al., who linked high BMI to both lower functional outcomes and lower HRQoL [6].
Treatment Modalities: Limb Salvage vs. Amputation
Literature consistently demonstrates that patients undergoing limb-salvage surgeries achieve superior functional scores and HRQoL compared to those undergoing amputation [3,12,13,14]. For instance, Thoms, et al. reported significantly higher TESS scores in limb salvage groups (p
Role of Radiotherapy and Complications
Adjuvant treatments such as radiotherapy are known to cause temporary functional declines [2]. Götzl, et al. found that neoadjuvant radiochemotherapy was associated with significantly worse global QoL and physical functioning compared to surgery alone [5]. Wound complications also play a critical role; Ramu et al. noted that post-operative wound issues correlate with increased disability and lower functional scores for up to 24 months [2]. Our study reported a low incidence of wound infection, which may contribute to the relatively high functional stability observed.
Study Limitations
Short Follow-Up Duration: The three-month follow- up period in our study is insufficient to capture long-term functional plateaus or late effects of radiotherapy, which typically manifest after one year [4,11]. Sample Size and Setting: The sample of 46 patients from a single tertiary center limits the generalizability of the findings to broader populations or varied healthcare settings. Demographic Gaps: The study lacked representation of the 70–79 age group, limiting insights into the outcomes of the most elderly and potentially frail patients [15].
Future Directions
There is a need for prospective, multicenter longitudinal studies that follow patients for 5–10 years to understand the long-term interaction between aging, late treatment toxicities, and quality of life. Furthermore, research should explore the psychological factors that decouple physical functionality from overall quality of life during early recovery.
Conclusion
Limb-salvage surgery for extremity soft tissue sarcoma yields high and stable early functional scores and acceptable quality of life. Older age and elevated BMI independently predict poorer outcomes and should prompt intensified perioperative optimisation and rehabilitation. Larger prospective multicentre studies with longer follow-up and standardised oncologic endpoints are required to refine patient selection and treatment algorithms in the Indian context.
References
1. Gazendam A, Schneider P, Heels-Ansdell D, Bhandari M, Busse JW, et al. (2022) Predictors of Functional Recovery among Musculoskeletal Oncology Patients Undergoing
Lower Extremity Endoprosthetic Reconstruction. Current Oncology 29(10): 7598-7606.
2. Green C, Nguyen N, Wylie JD, Choudhury A, Gregory JJ (2015) The treatment of periarticular soft tissue sarcoma following neo-adjuvant radiotherapy: a cohort study. World Journal of Surgical Oncology 13: 108-108.
3. Ramu EM, Houdek MT, Isaac CE, Dickie CI, Ferguson PC, et al. (2017) Management of soft-tissue sarcomas; treatment strategies, staging, and outcomes. SICOT J 3: 20.
4. Götzl R, Sterzinger S, Semrau S, Vassos N, Hohenberger W, et al. (2019) Patient’s quality of life after surgery and radiotherapy for extremity soft tissue sarcoma - a retrospective single-center study over ten years. Health and Quality of Life Outcomes 17(1): 170.
5. Podleska LE, Kaya N, Farzaliyev F, Pöttgen C, Bauer S, et al. (2017) Lower limb function and quality of life after ILP for soft-tissue sarcoma. World Journal of Surgical Oncology 15(1): 84-84.
6. Kask G, Repo JP, Tukiainen E, Blomqvist C, Blomqvist C, et al. (2021) Soft Tissue Sarcoma of Lower Extremity: Functional Outcome and Quality of Life. Annals of Surgical Oncology 28(11): 6892-6905.
7. Xu L, Li X, Wang Z, Xiong J, Wang S (2017) Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system. Health and Quality of Life Outcomes 15(1): 107-107.
8. Oh E, Seo SW, Han KJ (2018) A Longitudinal Study of Functional Outcomes in Patients with Limb Salvage Surgery for Soft Tissue Sarcoma. Sarcoma 2018(2018): 6846275-6846275.
9. Silva RS, Guilhem D, Batista KT, Tabet LP (2019) Quality of life of patients with sarcoma after conservative surgery or amputation of limbs. Acta Ortopedica Brasileira 27(5): 276-280.
10. Kask G, Barner-Rasmussen I, Repo JP, Kjäldman M, Kilk K, et al. (2019) Functional Outcome Measurement in Patients with Lower-Extremity Soft Tissue Sarcoma: A Systematic Literature Review. Annals of Surgical Oncology 26(13): 4707-4722.
11. Bolia IK, Savvidou OD, Kang HP, Chatzichristodoulou N, Megaloikonomos PD, et al. (2021) Cross-cultural adaptation and validation of the Musculoskeletal Tumor Society (MSTS) scoring system and Toronto Extremity Salvage Score (TESS) for musculoskeletal sarcoma patients in Greece. European Journal of Orthopaedic Surgery and Traumatology 31(8): 1631-1638.
12. Reijers SJM, Husson O, Soomers VLMN, Been LB, Bonenkamp JJ, et al. (2022) Health-related quality of life after isolated limb perfusion compared to extended resection, or amputation for locally advanced extremity sarcoma: Is a limb salvage strategy worth the effort? EJSO 48(3): 500-507.
13. Kinoshita H, Kinoshita S, Hagiwara Y, Kamoda H, Ohtori S, et al. (2023) Postoperative Limb Function and QOL in Elderly Patients with Malignant Bone Tumor/Soft Tissue Sarcoma. Anticancer Research 43(7): 3273-3279.
14. Binziad SA, Alyamani AS, Baeesa KA, Kaleem WK, Bakarman AA, et al. (2019) Impact of Loco-regional Surgical Control on Survival of Extremity Soft Tissue Sarcoma among Patients of Hadhramout National Cancer Center. Advances in Surgical Sciences 7(1): 15.
15. Uehara K, Ogura K, Akiyama T, Shinoda Y, Iwata S, et al. (2017) Reliability and Validity of the Musculoskeletal Tumor Society Scoring System for the Upper Extremity in Japanese Patients. Clinical Orthopaedics and Related Research 475(9): 2253-2259.
References
- Gazendam A, Schneider P, Heels-Ansdell D, Bhandari M, Busse JW, et al. (2022) Predictors of Functional Recovery among Musculoskeletal Oncology Patients Undergoing Lower Extremity Endoprosthetic Reconstruction. Current Oncology 29(10): 7598-7606.
- Green C, Nguyen N, Wylie JD, Choudhury A, Gregory JJ (2015) The treatment of periarticular soft tissue sarcoma following neo-adjuvant radiotherapy: a cohort study. World Journal of Surgical Oncology 13: 108-108.
- Ramu EM, Houdek MT, Isaac CE, Dickie CI, Ferguson PC, et al. (2017) Management of soft-tissue sarcomas; treatment strategies, staging, and outcomes. SICOT J 3: 20.
- Götzl R, Sterzinger S, Semrau S, Vassos N, Hohenberger W, et al. (2019) Patient’s quality of life after surgery and radiotherapy for extremity soft tissue sarcoma - a retrospective single-center study over ten years. Health and Quality of Life Outcomes 17(1): 170.
- Podleska LE, Kaya N, Farzaliyev F, Pöttgen C, Bauer S, et al. (2017) Lower limb function and quality of life after ILP for soft-tissue sarcoma. World Journal of Surgical Oncology 15(1): 84-84.
- Kask G, Repo JP, Tukiainen E, Blomqvist C, Blomqvist C, et al. (2021) Soft Tissue Sarcoma of Lower Extremity: Functional Outcome and Quality of Life. Annals of Surgical Oncology 28(11): 6892-6905.
- Xu L, Li X, Wang Z, Xiong J, Wang S (2017) Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system. Health and Quality of Life Outcomes 15(1): 107-107.
- Oh E, Seo SW, Han KJ (2018) A Longitudinal Study of Functional Outcomes in Patients with Limb Salvage Surgery for Soft Tissue Sarcoma. Sarcoma 2018(2018): 6846275-6846275.
- Silva RS, Guilhem D, Batista KT, Tabet LP (2019) Quality of life of patients with sarcoma after conservative surgery or amputation of limbs. Acta Ortopedica Brasileira 27(5): 276-280.
- Kask G, Barner-Rasmussen I, Repo JP, Kjäldman M, Kilk K, et al. (2019) Functional Outcome Measurement in Patients with Lower-Extremity Soft Tissue Sarcoma: A Systematic Literature Review. Annals of Surgical Oncology 26(13): 4707-4722.
- Bolia IK, Savvidou OD, Kang HP, Chatzichristodoulou N, Megaloikonomos PD, et al. (2021) Cross-cultural adaptation and validation of the Musculoskeletal Tumor Society (MSTS) scoring system and Toronto Extremity Salvage Score (TESS) for musculoskeletal sarcoma patients in Greece. European Journal of Orthopaedic Surgery and Traumatology 31(8): 1631-1638.
- Reijers SJM, Husson O, Soomers VLMN, Been LB, Bonenkamp JJ, et al. (2022) Health-related quality of life after isolated limb perfusion compared to extended resection, or amputation for locally advanced extremity sarcoma: Is a limb salvage strategy worth the effort? EJSO 48(3): 500-507.
- Kinoshita H, Kinoshita S, Hagiwara Y, Kamoda H, Ohtori S, et al. (2023) Postoperative Limb Function and QOL in Elderly Patients with Malignant Bone Tumor/Soft Tissue Sarcoma. Anticancer Research 43(7): 3273-3279.
- Binziad SA, Alyamani AS, Baeesa KA, Kaleem WK, Bakarman AA, et al. (2019) Impact of Loco-regional Surgical Control on Survival of Extremity Soft Tissue Sarcoma among Patients of Hadhramout National Cancer Center. Advances in Surgical Sciences 7(1): 15.
- Uehara K, Ogura K, Akiyama T, Shinoda Y, Iwata S, et al. (2017) Reliability and Validity of the Musculoskeletal Tumor Society Scoring System for the Upper Extremity in Japanese Patients. Clinical Orthopaedics and Related Research 475(9): 2253-2259.